Search - tctmd.com

Displaying 341 - 360 of 824

Sort: Relevancy | Date

News Conference News AHA 2018

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

Yael L. Maxwell

November 10, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Daily News

Low Temps, Harsh Weather Linked to MI Risk, Swedish Study Confirms

Caitlin E. Cox

October 25, 2018

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

News Daily News

Plaque Characteristics on OCT Offer Clues About Atherosclerotic Causes of MINOCA

Caitlin E. Cox

October 23, 2018

News Daily News

New Point-of-Care Troponin Assay Shows Promise for Ruling Out MI

Todd Neale

October 17, 2018

News Daily News

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

L.A. McKeown

October 16, 2018

Presentation TCT 2018

Controlled Flow Infusion: A New Approach to Measure Dynamic Microvascular Resistance and to Treat Microvascular Obstruction in Acute Heart Attack Patients in the Cath Lab: CorFlowTherapeutics AG

Presenter: Louis A. Cannon, Juan F. Granada, Jon H Hoem

September 22, 2018

News Daily News

Readmissions High When Patients Leave Hospital Against Medical Advice After Acute MI

Todd Neale

September 19, 2018

News Daily News

Aspirin Falters Yet Again in Primary Prevention: ASPREE

Michael O'Riordan

September 17, 2018

News Industry News

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

September 05, 2018

News Conference News ESC 2018

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Shelley Wood

August 31, 2018

News Conference News ESC 2018

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

Shelley Wood

August 29, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Daily News

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Michael O'Riordan

August 16, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

News Daily News

Women With Acute MI More Likely to Survive If Treated by Female Physicians

Shelley Wood

August 08, 2018

News Daily News

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

Todd Neale

August 01, 2018

Advertisement

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Low Temps, Harsh Weather Linked to MI Risk, Swedish Study Confirms

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Plaque Characteristics on OCT Offer Clues About Atherosclerotic Causes of MINOCA

New Point-of-Care Troponin Assay Shows Promise for Ruling Out MI

CAC Scoring Is Predictive of Risk Across Races and Ethnicities

Controlled Flow Infusion: A New Approach to Measure Dynamic Microvascular Resistance and to Treat Microvascular Obstruction in Acute Heart Attack Patients in the Cath Lab: CorFlowTherapeutics AG

Readmissions High When Patients Leave Hospital Against Medical Advice After Acute MI

Aspirin Falters Yet Again in Primary Prevention: ASPREE

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Women With Acute MI More Likely to Survive If Treated by Female Physicians

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content